journal article·2020-03

Crystal structure of bisoprolol fumarate Form I, (C 18 H 32 NO 4 ) (C 4 H 2 O 4 ) 0.5

James A. Kaduk, Amy M. Gindhart, Thomas N. Blanton

Powder Diffraction· Volume 35· Issue 1
Publisher page

Abstract

The crystal structure of bisoprolol fumarate Form I has been solved and refined using synchrotron X-ray powder diffraction data and optimized using density functional techniques. Bisoprolol fumarate Form I crystallizes in space group P -1 (#2) with a = 8.165 70(5) Å, b = 8.516 39(12) Å, c = 16.751 79(18) Å, α = 89.142(1)°, β = 78.155(1)°, γ = 81.763(1)°, V = 1128.265(10) Å 3 , and Z = 2. The neutral side chain of the bisoprolol cation is probably disordered. The cation and anion are linked by N–H⋯O and O–H⋯O hydrogen bonds. The cations are also linked by N–H⋯O hydrogen bonds. The result is alternating layers of hydrophilic and hydrophobic layers parallel to the ab -plane. The density of the structure is relatively low at 1.130 g cm −3 , but there are no obvious voids in the structure. The powder pattern is included in the Powder Diffraction File™ as entry 00-066-1625.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: X-ray Diffraction in Crystallography · Crystallography and molecular interactions · Polymer Synthesis and Characterization

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (35)

Show source-provided references
1. 10.1017/S088571561400051710.1017/S0885715614000517 ↗
2. 10.1107/S205252061800233010.1107/S2052520618002330 ↗
3. 10.1107/S090904950801843810.1107/S0909049508018438 ↗
4. Larson, A. C. and Von Dreele, R. B. (2004). "General Structure Analysis System (GSAS)," Los Alamos National Laboratory Technical Report LAUR 86–784.
5. 10.1063/1.296926010.1063/1.2969260 ↗
6. 2017
7. Bravais · 1866
8. Etudes sur la loi de Bravais
9. 10.1002/anie.19951555110.1002/anie.199515551 ↗
10. Open Babel: an open chemical toolbox
11. 2016
12. 10.1107/S205252061402290210.1107/S2052520614022902 ↗
13. 10.1021/ci049780b10.1021/ci049780b ↗
14. 10.1017/S088571561700028810.1017/S0885715617000288 ↗
15. 10.1002/qua.2465810.1002/qua.24658 ↗
16. 10.1107/S002188980706790810.1107/S0021889807067908 ↗
17. 10.1063/1.46788210.1063/1.467882 ↗
18. 2013
19. 10.1007/s10973-018-7553-810.1007/s10973-018-7553-8 ↗
20. 10.1107/S002188988708709010.1107/S0021889887087090 ↗
21. 10.1107/S002188981101462210.1107/S0021889811014622 ↗
22. 10.1016/0927-0256(96)00008-010.1016/0927-0256(96)00008-0 ↗
23. 2017
24. 10.1107/S002188981300353110.1107/S0021889813003531 ↗
25. 10.1017/S088571561800082910.1017/S0885715618000829 ↗
26. 10.1107/S002188980100224210.1107/S0021889801002242 ↗
27. 10.1107/S002188989800600110.1107/S0021889898006001 ↗
28. 2017
29. A new law of crystal morphology extending the law of Bravais
30. 10.1107/S002188989400421810.1107/S0021889894004218 ↗
31. Wang, Y. , Li, X. , Lu, T. , Peng, Y. , and Fan, Y. (2016). “Bisoprolol fumarate I crystal form and preparation method thereof,” Chinese Patent Application CN 10634909.
32. 10.1107/S002188981301311310.1107/S0021889813013113 ↗
33. 10.1021/ar00172a00510.1021/ar00172a005 ↗
34. 10.1107/S205252061600395410.1107/S2052520616003954 ↗
35. 10.1107/S010876819901508610.1107/S0108768199015086 ↗